BBLG
Bone Biologics Corp Common Stock
stockNASDAQ
At CloseOct 22, 2026 2:32:50 PM EDT
0.41USD-3.357%(-0.01)25,138
BBLG Financials
In Q2 FY 2026 (ended ), Bone Biologics Corp Common Stock (BBLG) reported revenue of $0, net income of −$773.7K, operating cash flow of −$518.44K, and assets of $4.44M.
Loading financial statements…